leadf
logo-loader
viewRyanair Holdings PLC

Ryanair and Wizz Air report double-digit passenger growth in December

Ryanair reported passenger numbers of 10.3mln for December, up 12% year-on-year while its load factor was at 95%

Ryanair and Wizz Air planes
Wizz Air reported passenger numbers for the month had risen 18.3% YOY to around 2.6mln

Budget airlines Ryanair Holdings PLC (LON:RYA) and Wizz Air Holdings PLC (LON:WIZZ) have reported double-digit growth in passenger numbers for the month of December.

Ryanair reported passenger numbers for the month of 10.3mln, up 12% year-on-year (YOY) while its load factor was at 95%.

READ: Wizz Air and Ryanair report traffic growth in November as latter inks agreement with German pilot’s union

This was broken down to 10mln passengers for its main Ryanair division, up 9% YOY, and 0.3mln passengers for its Laudamotion arm.

On a rolling annual basis, the firm said it had carried 139.2mln passengers, up 8% YOY wit over 81% of its 57,000 scheduled December flights arriving on time.

Meanwhile, Wizz Air reported passenger numbers for the month had risen 18.3% YOY to around 2.6mln while the load factor increased 1.3 percentage points (ppts) to 88.8%.

In the rolling 12 months, Wizz Air passenger numbers were up 19.6% at 33.8mln while the load factor rose 1 ppt to 92.4%.

The group also increased its capacity in December by 16.5% to 2.99mln and added 14 new routes.

In early trading Thursday, Ryanair shares were up 0.1% at 10.5p while Wizz Air shares were up 1.6% at 2,798p.

--Adds share price--

Quick facts: Ryanair Holdings PLC

Price: 16.535 EUR

LSE:RYA
Market: LSE
Market Cap: €18.64 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Bionomics' positive pharmacokinec results confirms it can begin second Phase...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 2 hours ago

2 min read